Atacand 8 mg tablets
Authorisation PPA1463/031/001 · IMED Healthcare Ltd.,
- Licence holder
- IMED Healthcare Ltd., (all products →)
- Active substance
- Candesartan cilexetil
- Dosage form
- Tablet
- Route of administration
- Oral use
- ATC codes
- C09CA, C09CA06
- First authorised
- 05/02/2010
- Prescription status
- Product subject to prescription which may be renewed (B)
- Supply
- Supply through pharmacies only
- Legal basis
- Parallel importation notified in accordance with Article 76(3) of Directive 2001/83/EC
Candesartan cilexetil: supply and approvals
38 authorised products on the HPRA list contain Candesartan cilexetil. Shortage records below are for the substance in the EU, US and German markets and may not affect this Irish product; for Irish supply, check with the HPRA or a pharmacist.
- EU shortage (EMA)
- No entry in the EMA shortage catalogue (checked 17 Nov 2026)
- US shortage (FDA)
- No entry in the FDA drug shortage list (checked 17 Nov 2026)
- Germany (BfArM)
- No entry in the BfArM supply notices (checked 17 Nov 2026)
Registers: EU shortages · US shortages · German shortages · EMA approvals
About this licence
Parallel import (PPA). A parallel product authorisation: the HPRA allows this product to be imported from another EU or EEA country and sold in Ireland. It has been authorised for 16 years (since 5 February 2010). The HPRA list does not say whether it is on sale.
Other medicines with Candesartan cilexetil in Ireland
37 other products on the HPRA list contain Candesartan cilexetil, from 7 licence holders; 15 of them are marked as marketed. Products with the same substance can differ in strength, form, other ingredients and what they are licensed for, so they are not automatically interchangeable.
| Medicine | Licence holder | Licence | Status |
|---|---|---|---|
| Atacand 16 mg tablets | CHEPLAPHARM Arzneimittel GmbH | National authorisation (PA) | Marketed |
| Atacand 8 mg tablets | CHEPLAPHARM Arzneimittel GmbH | National authorisation (PA) | Marketed |
| Atacand Plus 16 mg/12.5 mg tablets | CHEPLAPHARM Arzneimittel GmbH | National authorisation (PA) | Marketed |
| Candesartan 16 mg tablets | Accord Healthcare Ireland Ltd. | National authorisation (PA) | Marketed |
| Candesartan 4 mg Tablets | Accord Healthcare Ireland Ltd. | National authorisation (PA) | Marketed |
| Candesartan 8 mg tablets | Accord Healthcare Ireland Ltd. | National authorisation (PA) | Marketed |
| Candesartan Clonmel 16 mg tablets | Clonmel Healthcare Ltd | National authorisation (PA) | Marketed |
| Candesartan Clonmel 4 mg tablets | Clonmel Healthcare Ltd | National authorisation (PA) | Marketed |
| Candesartan Clonmel 8 mg tablets | Clonmel Healthcare Ltd | National authorisation (PA) | Marketed |
| Candesartan Hydrochlorothiazide Krka 16mg/12.5mg tablets | KRKA, d.d., Novo mesto | National authorisation (PA) | Marketed |
| Candesartan Krka 16 mg tablets | KRKA, d.d., Novo mesto | National authorisation (PA) | Marketed |
| Candesartan Krka 4 mg tablets | KRKA, d.d., Novo mesto | National authorisation (PA) | Marketed |
Other substances in ATC group C09CA
The ATC system groups medicines by the part of the body they act on and their chemistry. On the HPRA list, 9 other active substances share the group C09CA with this product:
Telmisartan (34) · Valsartan (26) · Irbesartan (24) · Losartan potassium (18) · Olmesartan medoxomil (18) · Hydrochlorothiazide (4) · Azilsartan medoxomil (3) · Eprosartan (3) · Hydrocholothiazide (1)
Numbers in brackets are products on the HPRA list. Sharing an ATC group does not mean two medicines can replace each other.
The licence holder
IMED Healthcare Ltd., holds 178 products on the HPRA list, with 119 different active substances; 1 of the products is marked as marketed.
This listing is regulatory information, not medical advice — consult the package leaflet, SPC, or a healthcare professional. For the authoritative record see the HPRA register.
How this page is built
The facts on this page are pulled directly from the HPRA's (Health Products Regulatory Authority) official open dataset — they are not written from memory, and nothing here is summarised or edited. Each field below names the dataset it came from, so you can check it yourself.
- HPRA Authorised Medicines List (open data) ↗ Licence number, holder, active substance(s), dosage form, route, ATC code(s), authorisation date and prescription status for this product
This page is built automatically: a daily sync job downloads HPRA's published XML export and copies the licence number, holder, active substance(s), dosage form, route, ATC code(s), authorisation date and prescription status directly into this page — no AI drafting and no per-product editorial pass. The “last verified” date above is the timestamp of that sync, not a review date. Our general editorial approach is described in our editorial standards and corrections policy. The HPRA data on this page was last retrieved on 18 Nov 2026. How every register is built: methodology · fixes we have made: corrections log.